|URGENT NEED of MONEY : |
GO to the page SAVE the Atlas and DONATE
|ICD-Topo||C079-C081,C088-C089 SALIVARY GLAND|
|ICD-Morpho||8561/0 Warthin tumour|
|Phylum||Head and Neck:Salivary gland:Warthin's tumor cystadenolymphoma (parotid or submaxillary gland)|
|Note|| Warthin's tumor is the second most common benign salivary gland tumor, which is located almost exclusively in the parotid gland. Warthin's tumor accounts for about 15% of all epithelial tumors of the parotid gland.
The initial description of the tumor goes back to Hildebrand in 1895, who considered this disease a variant of congenital epithelial cyst of the neck. In 1910, Albrecht and Arzt reported two tumors of the upper neck region which they interpreted as confused tissue in the entodermal pharyngeal anlage, particularly that of salivary glands, in the lymph nodes. They called them papillary cystadenomas in lymph nodes. In the WHO classification, the disease was named Warthin's tumor after the pathologist who published the first two case reports in the American literature in 1929. He gave the tumor the name papillary cystadenoma lymphomatosum and regarded it as heterotopia of the mucous membrane of the accessory eustachian tube anlage. The term Warthin's tumor was chosen later, in order to avoid confusion with malignant lymphomas.
|Clinics and Pathology|
|Note|| Warthin's tumors most commonly present as an asymptomatic, slowly growing round or oval mass usually affecting men in the 5th and 6th decade. The male to female ratio ranges from 2.6:1 to 10:1. They occur extremely rarely in patients of Black African origin. The average size of Warthin's tumor at diagnosis is about 2.5 centimeter. The great majority of these tumors are located in the lower pole of the parotid gland. In about 12% of cases, there is bilateral tumor development, which is commonly synchronous. In about 6% of cases, multiple Warthin's tumors may be observed in one parotid gland. They may occur simultaneously with pleomorphic adenomas, various types of carcinoma and malignant lymphomas. |
In large registries, Warthin's tumors located outside of the parotid gland account for about 8% of the cases. Case reports concern particularly cervical lymph nodes, the submandibular gland, and the larynx. The author assume that more attention is paid to these rather rare locations than to the numerous Warthin's tumors located in the parotid gland which are extirpated worldwide.
|Embryonic origin|| Although various theories have been put forward to explain the development of Warthin's tumor, only two have ultimately remained. The first is the hypothesis of heterotopia; the second is the theory that this tumor is an adenoma with concomitant lymphocytic infiltration. According to the latter theory, when they are small and have a short history, Warthin's tumors consist mainly of epithelial components, while when they are large they show, in addition to their epithelial component, a lymphoid stroma. This theory was disproved by studies; that showed that the epithelial tumor components, like the lymphocytic infiltrations, are polyclonal. If, however, neoplasia is defined as a monoclonal process, this kind of tumor cannot be considered to be a true neoplasm.|
After Albrecht and Arzt (1910) a large number of studies drew the conclusion that this tumor develops due to salivary gland heterotopia in peri- and intraparotideal lymph nodes. During the embryogenesis of the parotid gland, epithelial cells from the oral mucosa happen to penetrate into lymphocyte-rich tissue. The late encapsulation of the parotid gland explains the occurrence of intraparotideal lymph nodes and heterotopic salivary gland remnants entrapped in the parotideal lymph nodes. According to this theory, Warthin's tumors have their origin in these epithelial inclusions. This hypothesis is further supported by the occurrence of tuberculosis, metastases and malignant lymphomas in the lymphoid stroma of those tumors. The extraparotid location and multicentric nature of these tumors can be explained by the last-mentioned hypothesis.
Other studies discussed the importance of immunological reactions during the formation of Warthin's tumor. A number of immunohistochemical findings indicate that there is an immunological interaction between epithelium and lymphoid stroma. These results support the assumption that oncocytic cells represent the true tumor component and cause reactive hyperplasia of the lymphoid stroma. In this context, further similarities between the lymphoid components of the tumor and the lymphoid tissue of the intestinal mucosa were found.
The details of the pathogenesis of Warthin's tumor are still unclear. However, because of the arguments against a true neoplastic origin of this tumor, the author favour a hypothesis combining immunological interactions between tumor cells and lymphocytic infiltrations with heterotopia.
In the WHO classification of salivary gland tumors, certain diseases of the salivary glands are considered tumor-like lesions. Warthin's tumor may therefore also be classified in the group of tumor-like lesions, since both the epithelial and lymphoid tumor components are polyclonal in origin. The almost total lack of recurrence and malignant transformation of this tumor, similar to the situation in congenital lateral cervical cysts, further supports this view. Multicentricity at first excision and growth from a new focus seem to be responsible for the cases of recurrence reported in the literature. Malignant transformation of this tumor, if it ever occurs, is extremely rare. Most cases of reported malignancy can be attributed to a second tumor in association with Warthin's tumor.
|Etiology|| Several studies showed that a significant number of patients suffering from Warthin's tumor are smokers, in contrast to patients with other salivary gland tumors. The great majority of patients with Warthin's tumor had a history of over 20 years of smoking. The odds ratio for the incidence of Warthin's tumor among current smokers compared with never smokers was 8.3. Compared with never smokers, clearly higher odds of Warthin's tumor was observed in heavy smokers (more than 30 pack-years) (odds ratio=24.1) than patients who smoked less than 30 pack-years (odds ratio=4.9). Smoking was discussed as an important etiological factor. |
Warthin's tumor consists of oncocytic cells containing numerous mitochondria frequently showing structural abnormalities and reduced metabolic function. Smoking can lead to damage to mitochondrial DNA due to the development of numerous reactive oxygen species. In this context, a high rate of deleted mitochondrial DNA has been detected in the oncocytic cells of Warthin's tumor.
The role of hormones in the etiology of this disease has also been discussed. In some malignant salivary gland diseases and even in Warthin's tumor progesterone receptors have been found. A correlation with sex hormones could possibly play an important role in the development of those tumors and provide an explanation for the dominance of the male gender. However, it must be considered that more males than females used to smoke so that the role of the individual factors remains unclear and the intrinsic factor stimulating the development of Warthin's tumor is still unknown.
|A sixty years old man with Warthin's tumor of the left parotid gland.|
|Pathology||These tumors are well encapsulated lesions with cystic and solid areas. These tumors consist of an oncocytic epithelial cell component arranged in double layers, which develops cysts and papillary projections, and a variable amount of lymphoid tissue often with germinal centers. The immunoprofile of the lymphocyte subsets is similar to that in normal or reactive lymph nodes. A few Warthin's tumors (about 8%) show areas of squamous cell metaplasia and regressive changes.|
|Warthin's tumor. Two histologic components are required for the diagnosis: the eosinophilic oncocytes and a lymphoid element.|
|Treatment||On the basis of the clinical characteristics, a limited partial parotidectomy is recommended as an effective treatment of Warthin's tumor of the parotid gland.|
|Note|| Few Studies have shown clonal genetic abnormalities at the cytogenetic level. However, other later studies showed a polyclonal pattern in Warthin's tumor. Other data demonstrated that Warthin's tumor do not have evidence of DNA mismatch repair defects at the genomic or protein expression level. These results argue against a general neoplastic origin.|
The cytogenetic data available on this tumor are rather scare. However, analysis of cytogenetic findings revealed, beside normal karyotypes, also structural alterations and numerical deviations in some cases. t(11;19)(q21;p13) translocation with expression of chimeric genes CRTC1 - MAML2 is a very rare event in Warthin's tumor. Identification of cytogenetic subgroups in Warthin's tumor may suggest that it might be a pathogenetically heterogeneous group of lesions. When the fusion gene is present in this tumor type, it seems to be restricted in special cases with indeterminate morphology, especially involving necrosis and subsequent metaplasia.
Deletions of mitochondrial DNA is significantly higher in oncocytic tumor cells than parotid epithelia cells. In this context damage of mitochondrial DNA as a result of an increase in oxidative damage of cigarette smoke could be discussed.
|Other genes implicated (Data extracted from papers in the Atlas)|
|Translocations implicated (Data extracted from papers in the Atlas)|
|Mitelman database||t(11;19)(q21;p13) CRTC1/MAML2 [Case List] t(11;19)(q21;p13) CRTC1/MAML2 [Association List] Mitelman database (CGAP - NCBI)|
|COSMIC||Histo = - Site = salivary_gland (COSMIC)|
|arrayMap||Topo ( C07,C8,C08) Morph ( 8561/0) - arrayMap (Zurich)|
|Warthin's tumor: a hypersensitivity disease? Ultrastructural, light, and immunofluorescent study.|
|Hum Pathol. 1971; 2: 403-420.|
|Expression of major histocompatibility complex class II antigens and interleukin-1 by epithelial cells of Warthin's tumor.|
|Ogawa Y, Hong SS, Toyosawa S, Chang CC, Yagi T.|
|Cancer 1990; 66:2111-2117.|
|Cytogentic characterisation of Warthin's tumour.|
|Martins C, Fonseca I, Roque L, Soares J.|
|Oral Oncol. 1997; 33: 344-347.|
|Warthin tumor. A new hypothesis concerning its development.|
|Aguirre JM, Echebarria MA, Martinez-Conde R, Rodriguez C, Burgos JJ, Rivera JM .|
|Oral Surg Oral Med Oral Pathol Oral Radiol Endo. 1998; 85: 6063.|
|Clonal analysis of the epithelial component of Warthin's tumor.|
|Honda K, Kashima K, Daa T, Yokoyama S, Nakayama I.|
|Hum Pathol. 2000; 31: 1377-1380.|
|Detection of damage to the mitochondrial genome in the oncocytic cells of Warthin's tumour.|
|Lewis PD, Baxter P, Paul Griffiths A, Parry JM, Skibinski DO.|
|J Pathol. 2000; 191: 274-281.|
|Steroid hormone receptors in parotid gland cystadenolymphoma (Warthin's tumour).|
|Teymoortash A, Lippert BM, Werner JA.|
|Clin Otolaryngol Allied Sci. 2001; 26: 411-6.|
|Tissue that has lost its track: Warthin's tumour.|
|Teymoortash A, Werner JA.|
|Virchows Arch. 2005; 446: 585-8.|
|Clinical features of cystadenolymphoma (Warthin's tumor) of the parotid gland: a retrospective comparative study of 96 cases.|
|Teymoortash A, Krasnewicz Y, Werner JA.|
|Oral Oncol. 2006; 42: 569-73.|
|Evidence of lymphangiogenesis in Warthin's tumor of the parotid gland.|
|Teymoortash A, Schrader C, Shimoda H, Kato S, Werner JA.|
|Oral Oncol. 2007; 43: 614-8.|
|A closer look at Warthin tumors and the t(11;19).|
|Fehr A, Roser K, Belge G, Loning T, Bullerdiek J.|
|Cancer Genet Cytogenet. 2008; 180: 135-9.|
|REVIEW articles||automatic search in PubMed|
|Last year articles||automatic search in PubMed|
|Department of Otolaryngology, Head and Neck Surgery, Philipp University, Deutschhaus Str. 3, 35037 Marburg, Germany|
|This paper should be referenced as such :|
|Head and neck: Salivary gland: Warthin's Tumors|
|Atlas Genet Cytogenet Oncol Haematol. 2009;13(4):312-315.|
|Free journal version : [ pdf ] [ DOI ]|
|On line version : http://AtlasGeneticsOncology.org/Tumors/WarthinsTumID5424.html|
|© Atlas of Genetics and Cytogenetics in Oncology and Haematology||indexed on : Thu Aug 20 13:15:49 CEST 2015|
For comments and suggestions or contributions, please contact us